| Literature DB >> 35223649 |
Mohsen Pourazizi1, Rasoul Mohammadi2, Bahareh Abtahi-Naeini3.
Abstract
Entities:
Year: 2022 PMID: 35223649 PMCID: PMC8837871 DOI: 10.18502/ijph.v51i1.8320
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Fig. 1:Experimental evaluation of a sample of Anbarnesa that was used in one of confirmed case of COVID-19-associated mucormycosis. a) Making a suspension of Anbarnesa in sterile saline solution 1:10 (w/v). b) Fuzzy colonies of zygomycetes on sabouraud glucose agar after 5 days at 30 °C. c) Microscopic feature of the Mucorales after 5 days at 30 °C showing sporangium (Black arrows), sporangiophore (blue arrows), and sporangiospores (white arrows)